(Sharecast News) - Verici Dx has announced a proposed equity fundraising of at least £5m on Monday, through a placing, subscription, and retail offer, aimed at accelerating the commercial rollout of its next-generation kidney transplant diagnostics.
The AIM-traded firm said the placing, priced at 0.5p per share, represented a 42.9% discount...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE